Bank of New York Mellon Corp - KEMPHARM INC ownership

KEMPHARM INC's ticker is KMPH and the CUSIP is 488445206. A total of 71 filers reported holding KEMPHARM INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of KEMPHARM INC
ValueSharesWeighting
Q2 2024$1,080,448
-6.5%
220,499
+10.7%
0.00%
Q1 2024$1,155,756
-13.0%
199,268
-1.7%
0.00%
Q4 2023$1,328,164
+35.9%
202,7730.0%0.00%
Q3 2023$977,365
-5.5%
202,773
-0.1%
0.00%
Q2 2023$1,034,704
+64.1%
202,883
+77.0%
0.00%
Q1 2023$630,444
+19.8%
114,6260.0%0.00%
Q4 2022$526,134
-28.7%
114,626
-3.0%
0.00%
Q3 2022$738,000
+40.0%
118,1660.0%0.00%
Q2 2022$527,000
-36.0%
118,166
-27.8%
0.00%
Q1 2022$823,000
+8.1%
163,617
+87.3%
0.00%
Q4 2021$761,000
-4.5%
87,344
+2.2%
0.00%
Q3 2021$797,000
-14.4%
85,454
+17.6%
0.00%
Q2 2021$931,00072,6450.00%
Other shareholders
KEMPHARM INC shareholders Q4 2022
NameSharesValueWeighting ↓
Altium Capital Management LP 1,162,416$5,695,8382.32%
Retirement Planning Co of New England, Inc. 458,300$2,245,6701.22%
Nantahala Capital Management 2,419,435$11,855,2320.70%
Mystic Asset Management, Inc. 297,947$1,459,9400.59%
683 Capital Management, LLC 800,000$3,920,0000.30%
AIGH Capital Management LLC 181,673$890,1970.28%
AIGH Capital Management LLC 137,600$674,2400.21%
Kovack Advisors, Inc. 149,532$732,7070.08%
Woodline Partners LP 1,147,583$5,623,1570.05%
Arete Wealth Advisors, LLC 78,413$3740.03%
View complete list of KEMPHARM INC shareholders